| AMEFX | IPFCX | AMEFX / IPFCX | |
| Total Expense Ratio | 0.37 | 0.90 | 41% |
| Annual Report Gross Expense Ratio | 0.37 | 1.45 | 26% |
| Fund Existence | 18 years | 12 years | - |
| Gain YTD | 8.815 | 14.242 | 62% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 25000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 150B | 37.3M | 402,145% |
| Annual Yield % from dividends | 3.55 | 2.26 | 157% |
| Returns for 1 year | 5.18 | 10.52 | 49% |
| Returns for 3 years | 39.42 | 34.85 | 113% |
| Returns for 5 years | 26.11 | 15.95 | 164% |
| Returns for 10 years | 62.25 | 57.77 | 108% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CDVZX | 21.51 | 0.15 | +0.70% |
| Columbia Intrinsic Value Institutional | |||
| FFOTX | 54.76 | N/A | N/A |
| Fidelity Advisor Technology - Z | |||
| FRBRX | 213.20 | N/A | N/A |
| Franklin Biotechnology Discovery R6 | |||
| BIREX | 16.30 | N/A | N/A |
| BlackRock Real Estate Securities Instl | |||
| EFEAX | 11.88 | N/A | N/A |
| Ashmore Emerging Mkts Frontier Eq A | |||